《大行》招银国际对中国医药股投资评级及目标价 (表)

AASTOCKS
2025.11.11 03:06

Zhao Yin International published a research report, listing the investment ratings and target prices for Chinese pharmaceutical stocks as follows:

Stock | Investment Rating | Target Price (HKD)

3SBIO (01530.HK) | Buy | 37.58

GUSHENGTANG (02273.HK) | Buy | 48.28

GIANT BIOGENE (02367.HK) | Buy | 58.35

WUXI XDC (02268.HK) | Buy | 74

INNOVENT BIO (01801.HK) | Buy | 110.62

SINO BIOPHARM (01177.HK) | Buy | 9.4

来源：AASTOCKS 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。